Add BrightSurf on Google Email

Controlling adhesions in the abdomen

Adhesions form after inflammation or surgery and can lead to chronic pain, digestive problems, infertility, and life-threatening consequences. Researchers have discovered that macrophages play a key role in their development and have developed a new imaging system to visualize them.

SourceUniversity of Bern·JournalScience·DateMar 5, 2021

Scientists switch on tissue repair in inflammatory bowel disease

Researchers at KU Leuven and Seoul National University create method to stimulate immune system cells to repair damaged tissues, offering new potential treatment for inflammatory bowel disease. The technique involves targeting specific macrophage cells with liposomes containing a substance that triggers tissue regeneration.

SourceKU Leuven·JournalGut·DateFeb 8, 2021

Stanford study reveals immune driver of brain aging

A Stanford study reveals that chronic inflammation driven by myeloid cells is the main driver of brain aging. The researchers found that blocking a specific hormone-receptor interaction in these cells can restore youthful metabolism and calm down inflammation, potentially reversing age-related cognitive decline.

SourceStanford Medicine·JournalNature·DateJan 20, 2021

Potential therapeutic strategy for obesity

Researchers have identified a potential therapeutic strategy for obesity by discovering the signalling pathways responsible for the development of adipose tissue macrophages (ATMs) in obesity. ATMs play a key role in preventing lipotoxicity, where fat molecules are deposited in non-adipose tissues.

SourceMedical University of Vienna·JournalNature Metabolism·DateNov 17, 2020

Study pinpoints target for managing inflammation, promoting tissue repair

A study by Cincinnati Children's Hospital Medical Center found that targeting the BCAP protein could help control overactive immune responses and promote tissue repair in inflammatory diseases. The researchers suggest that modulating BCAP activity could be used to dampen inflammation and accelerate response against tumors.

SourceCincinnati Children's Hospital Medical Center·JournalProceedings of the National Academy of Sciences·DateNov 16, 2020

Protein that keeps immune system from freaking out could form basis for new therapeutics

Researchers at University of California San Diego School of Medicine discovered a molecule called Girdin (GIV) that acts as a brake on macrophages. The GIV-mimic peptide can shut down immune cells' overreaction, supporting a mechanism critical for survival in mouse models of sepsis and colitis.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateOct 14, 2020

Fat crystals trigger chronic inflammation

Researchers at the University of Bonn identify a disease mechanism where fat crystals cause immune system hyperreaction, leading to chronic inflammation. The study reveals that deoxysphingolipid crystals disrupt mitochondrial function and activate an inflammatory response in immune cells.

SourceUniversity of Bonn·JournalAutophagy·DateAug 24, 2020

Assembly within the tumor center

Scientists discovered that identifying tumor-associated macrophage patterns in lung tumor tissue enables the prediction of disease progression. The study found that a higher number of tumor-promoting macrophages near the invasive margin is associated with lower patient survival rates.

SourceMax-Planck-Gesellschaft·JournalCancer Research·DateAug 4, 2020

Targeting the cancer microenvironment

A new biochemical switch involved in M2 macrophage polarization and proliferation has been identified, which can be targeted to inhibit cancer growth. The discovery was made by a research team from the University of Vienna and could lead to novel therapies against systemic diseases and cancer.

SourceUniversity of Vienna·JournalCell Reports·DateFeb 5, 2020